1 Market Overview

1.1 Bacterial Vaginosis OTC Drug Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Bacterial Vaginosis OTC Drug Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Pill

1.2.3 Gel

1.2.4 Cream

1.2.5 Other

1.3 Market Analysis by Application

1.3.1 Overview: Global Bacterial Vaginosis OTC Drug Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Pharmacy

1.3.3 On-line

1.3.4 Other

1.4 Global Bacterial Vaginosis OTC Drug Market Size & Forecast

1.4.1 Global Bacterial Vaginosis OTC Drug Sales in Value (2016-2026))

1.4.2 Global Bacterial Vaginosis OTC Drug Sales in Volume (2016-2026)

1.4.3 Global Bacterial Vaginosis OTC Drug Price by Type (2016-2026) & (US$/Unit)

1.5 Global Bacterial Vaginosis OTC Drug Production Capacity Analysis

1.5.1 Global Bacterial Vaginosis OTC Drug Total Production Capacity (2016-2026)

1.5.2 Global Bacterial Vaginosis OTC Drug Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Bacterial Vaginosis OTC Drug Market Drivers

1.6.2 Bacterial Vaginosis OTC Drug Market Restraints

1.6.3 Bacterial Vaginosis OTC Drug Trends Analysis

2 Manufacturers Profiles

2.1 Bayer

2.1.1 Bayer Details

2.1.2 Bayer Major Business

2.1.3 Bayer Bacterial Vaginosis OTC Drug Product and Services

2.1.4 Bayer Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Pfizer

2.2.1 Pfizer Details

2.2.2 Pfizer Major Business

2.2.3 Pfizer Bacterial Vaginosis OTC Drug Product and Services

2.2.4 Pfizer Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi Bacterial Vaginosis OTC Drug Product and Services

2.3.4 Sanofi Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Piramal

2.4.1 Piramal Details

2.4.2 Piramal Major Business

2.4.3 Piramal Bacterial Vaginosis OTC Drug Product and Services

2.4.4 Piramal Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Abbott

2.5.1 Abbott Details

2.5.2 Abbott Major Business

2.5.3 Abbott Bacterial Vaginosis OTC Drug Product and Services

2.5.4 Abbott Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Galderma

2.6.1 Galderma Details

2.6.2 Galderma Major Business

2.6.3 Galderma Bacterial Vaginosis OTC Drug Product and Services

2.6.4 Galderma Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Mission

2.7.1 Mission Details

2.7.2 Mission Major Business

2.7.3 Mission Bacterial Vaginosis OTC Drug Product and Services

2.7.4 Mission Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Alkem

2.8.1 Alkem Details

2.8.2 Alkem Major Business

2.8.3 Alkem Bacterial Vaginosis OTC Drug Product and Services

2.8.4 Alkem Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Xiuzheng

2.9.1 Xiuzheng Details

2.9.2 Xiuzheng Major Business

2.9.3 Xiuzheng Bacterial Vaginosis OTC Drug Product and Services

2.9.4 Xiuzheng Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Teva

2.10.1 Teva Details

2.10.2 Teva Major Business

2.10.3 Teva Bacterial Vaginosis OTC Drug Product and Services

2.10.4 Teva Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Perrigo

2.11.1 Perrigo Details

2.11.2 Perrigo Major Business

2.11.3 Perrigo Bacterial Vaginosis OTC Drug Product and Services

2.11.4 Perrigo Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 West-Ward

2.12.1 West-Ward Details

2.12.2 West-Ward Major Business

2.12.3 West-Ward Bacterial Vaginosis OTC Drug Product and Services

2.12.4 West-Ward Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 HPGC

2.13.1 HPGC Details

2.13.2 HPGC Major Business

2.13.3 HPGC Bacterial Vaginosis OTC Drug Product and Services

2.13.4 HPGC Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Yunnan Baiyao

2.14.1 Yunnan Baiyao Details

2.14.2 Yunnan Baiyao Major Business

2.14.3 Yunnan Baiyao Bacterial Vaginosis OTC Drug Product and Services

2.14.4 Yunnan Baiyao Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Starpharma

2.15.1 Starpharma Details

2.15.2 Starpharma Major Business

2.15.3 Starpharma Bacterial Vaginosis OTC Drug Product and Services

2.15.4 Starpharma Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.16 Novel

2.16.1 Novel Details

2.16.2 Novel Major Business

2.16.3 Novel Bacterial Vaginosis OTC Drug Product and Services

2.16.4 Novel Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.17 Edenvridge

2.17.1 Edenvridge Details

2.17.2 Edenvridge Major Business

2.17.3 Edenvridge Bacterial Vaginosis OTC Drug Product and Services

2.17.4 Edenvridge Bacterial Vaginosis OTC Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Bacterial Vaginosis OTC Drug Sales by Manufacturer

3.1 Global Bacterial Vaginosis OTC Drug Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Bacterial Vaginosis OTC Drug Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Bacterial Vaginosis OTC Drug

3.4 Market Concentration Rate

3.4.1 Top 3 Bacterial Vaginosis OTC Drug Manufacturer Market Share

3.4.2 Top 6 Bacterial Vaginosis OTC Drug Manufacturer Market Share

3.5 Global Bacterial Vaginosis OTC Drug Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Bacterial Vaginosis OTC Drug Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Bacterial Vaginosis OTC Drug Market Size by Region

4.1.1 Global Bacterial Vaginosis OTC Drug Sales in Volume by Region (2016-2026)

4.1.2 Global Bacterial Vaginosis OTC Drug Revenue by Region (2016-2026)

4.2 North America Bacterial Vaginosis OTC Drug Revenue (2016-2026)

4.3 Europe Bacterial Vaginosis OTC Drug Revenue (2016-2026)

4.4 Asia-Pacific Bacterial Vaginosis OTC Drug Revenue (2016-2026)

4.5 South America Bacterial Vaginosis OTC Drug Revenue (2016-2026)

4.6 Middle East and Africa Bacterial Vaginosis OTC Drug Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Bacterial Vaginosis OTC Drug Sales in Volume by Type (2016-2026)

5.2 Global Bacterial Vaginosis OTC Drug Revenue by Type (2016-2026)

5.3 Global Bacterial Vaginosis OTC Drug Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Bacterial Vaginosis OTC Drug Sales in Volume by Application (2016-2026)

6.2 Global Bacterial Vaginosis OTC Drug Revenue by Application (2016-2026)

6.3 Global Bacterial Vaginosis OTC Drug Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Bacterial Vaginosis OTC Drug Sales by Type (2016-2026)

7.2 North America Bacterial Vaginosis OTC Drug Sales by Application (2016-2026)

7.3 North America Bacterial Vaginosis OTC Drug Market Size by Country

7.3.1 North America Bacterial Vaginosis OTC Drug Sales in Volume by Country (2016-2026)

7.3.2 North America Bacterial Vaginosis OTC Drug Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Bacterial Vaginosis OTC Drug Sales by Type (2016-2026)

8.2 Europe Bacterial Vaginosis OTC Drug Sales by Application (2016-2026)

8.3 Europe Bacterial Vaginosis OTC Drug Market Size by Country

8.3.1 Europe Bacterial Vaginosis OTC Drug Sales in Volume by Country (2016-2026)

8.3.2 Europe Bacterial Vaginosis OTC Drug Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Type (2016-2026)

9.2 Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Application (2016-2026)

9.3 Asia-Pacific Bacterial Vaginosis OTC Drug Market Size by Region

9.3.1 Asia-Pacific Bacterial Vaginosis OTC Drug Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Bacterial Vaginosis OTC Drug Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Bacterial Vaginosis OTC Drug Sales by Type (2016-2026)

10.2 South America Bacterial Vaginosis OTC Drug Sales by Application (2016-2026)

10.3 South America Bacterial Vaginosis OTC Drug Market Size by Country

10.3.1 South America Bacterial Vaginosis OTC Drug Sales in Volume by Country (2016-2026)

10.3.2 South America Bacterial Vaginosis OTC Drug Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Type (2016-2026)

11.2 Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Application (2016-2026)

11.3 Middle East & Africa Bacterial Vaginosis OTC Drug Market Size by Country

11.3.1 Middle East & Africa Bacterial Vaginosis OTC Drug Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Bacterial Vaginosis OTC Drug Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Bacterial Vaginosis OTC Drug Typical Distributors

12.3 Bacterial Vaginosis OTC Drug Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Bacterial Vaginosis OTC Drug Revenue by Type, (USD Million), 2021-2026

Table 2. Global Bacterial Vaginosis OTC Drug Revenue by Application, (USD Million), 2021-2026

Table 3. Bayer Basic Information, Manufacturing Base and Competitors

Table 4. Bayer Major Business

Table 5. Bayer Bacterial Vaginosis OTC Drug Product and Services

Table 6. Bayer Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Pfizer Basic Information, Manufacturing Base and Competitors

Table 8. Pfizer Major Business

Table 9. Pfizer Bacterial Vaginosis OTC Drug Product and Services

Table 10. Pfizer Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Sanofi Basic Information, Manufacturing Base and Competitors

Table 12. Sanofi Major Business

Table 13. Sanofi Bacterial Vaginosis OTC Drug Product and Services

Table 14. Sanofi Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Piramal Basic Information, Manufacturing Base and Competitors

Table 16. Piramal Major Business

Table 17. Piramal Bacterial Vaginosis OTC Drug Product and Services

Table 18. Piramal Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Abbott Basic Information, Manufacturing Base and Competitors

Table 20. Abbott Major Business

Table 21. Abbott Bacterial Vaginosis OTC Drug Product and Services

Table 22. Abbott Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Galderma Basic Information, Manufacturing Base and Competitors

Table 24. Galderma Major Business

Table 25. Galderma Bacterial Vaginosis OTC Drug Product and Services

Table 26. Galderma Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Mission Basic Information, Manufacturing Base and Competitors

Table 28. Mission Major Business

Table 29. Mission Bacterial Vaginosis OTC Drug Product and Services

Table 30. Mission Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Alkem Basic Information, Manufacturing Base and Competitors

Table 32. Alkem Major Business

Table 33. Alkem Bacterial Vaginosis OTC Drug Product and Services

Table 34. Alkem Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Xiuzheng Basic Information, Manufacturing Base and Competitors

Table 36. Xiuzheng Major Business

Table 37. Xiuzheng Bacterial Vaginosis OTC Drug Product and Services

Table 38. Xiuzheng Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Teva Basic Information, Manufacturing Base and Competitors

Table 40. Teva Major Business

Table 41. Teva Bacterial Vaginosis OTC Drug Product and Services

Table 42. Teva Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Perrigo Basic Information, Manufacturing Base and Competitors

Table 44. Perrigo Major Business

Table 45. Perrigo Bacterial Vaginosis OTC Drug Product and Services

Table 46. Perrigo Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. West-Ward Basic Information, Manufacturing Base and Competitors

Table 48. West-Ward Major Business

Table 49. West-Ward Bacterial Vaginosis OTC Drug Product and Services

Table 50. West-Ward Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. HPGC Basic Information, Manufacturing Base and Competitors

Table 52. HPGC Major Business

Table 53. HPGC Bacterial Vaginosis OTC Drug Product and Services

Table 54. HPGC Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Yunnan Baiyao Basic Information, Manufacturing Base and Competitors

Table 56. Yunnan Baiyao Major Business

Table 57. Yunnan Baiyao Bacterial Vaginosis OTC Drug Product and Services

Table 58. Yunnan Baiyao Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Starpharma Basic Information, Manufacturing Base and Competitors

Table 60. Starpharma Major Business

Table 61. Starpharma Bacterial Vaginosis OTC Drug Product and Services

Table 62. Starpharma Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Novel Basic Information, Manufacturing Base and Competitors

Table 64. Novel Major Business

Table 65. Novel Bacterial Vaginosis OTC Drug Product and Services

Table 66. Novel Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 67. Edenvridge Basic Information, Manufacturing Base and Competitors

Table 68. Edenvridge Major Business

Table 69. Edenvridge Bacterial Vaginosis OTC Drug Product and Services

Table 70. Edenvridge Bacterial Vaginosis OTC Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 71. Global Bacterial Vaginosis OTC Drug Sales by Manufacturer (2019-2021e) & (K Units)

Table 72. Global Bacterial Vaginosis OTC Drug Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 73. Market Position of Manufacturers in Bacterial Vaginosis OTC Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 74. Global Bacterial Vaginosis OTC Drug Production Capacity by Company, (K Units): 2020 VS 2021

Table 75. Head Office and Bacterial Vaginosis OTC Drug Production Site of Key Manufacturer

Table 76. Bacterial Vaginosis OTC Drug New Entrant and Capacity Expansion Plans

Table 77. Bacterial Vaginosis OTC Drug Mergers & Acquisitions in the Past Five Years

Table 78. Global Bacterial Vaginosis OTC Drug Sales by Region (2016-2021e) & (K Units)

Table 79. Global Bacterial Vaginosis OTC Drug Sales by Region (2021-2026) & (K Units)

Table 80. Global Bacterial Vaginosis OTC Drug Revenue by Region (2016-2021e) & (USD Million)

Table 81. Global Bacterial Vaginosis OTC Drug Revenue by Region (2021-2026) & (USD Million)

Table 82. Global Bacterial Vaginosis OTC Drug Sales by Type (2016-2021e) & (K Units)

Table 83. Global Bacterial Vaginosis OTC Drug Sales by Type (2021-2026) & (K Units)

Table 84. Global Bacterial Vaginosis OTC Drug Revenue by Type (2016-2021e) & (USD Million)

Table 85. Global Bacterial Vaginosis OTC Drug Revenue by Type (2021-2026) & (USD Million)

Table 86. Global Bacterial Vaginosis OTC Drug Price by Type (2016-2021e) & (US$/Unit)

Table 87. Global Bacterial Vaginosis OTC Drug Price by Type (2021-2026) & (US$/Unit)

Table 88. Global Bacterial Vaginosis OTC Drug Sales by Application (2016-2021e) & (K Units)

Table 89. Global Bacterial Vaginosis OTC Drug Sales by Application (2021-2026) & (K Units)

Table 90. Global Bacterial Vaginosis OTC Drug Revenue by Application (2016-2021e) & (USD Million)

Table 91. Global Bacterial Vaginosis OTC Drug Revenue by Application (2021-2026) & (USD Million)

Table 92. Global Bacterial Vaginosis OTC Drug Price by Application (2016-2021e) & (US$/Unit)

Table 93. Global Bacterial Vaginosis OTC Drug Price by Application (2021-2026) & (US$/Unit)

Table 94. North America Bacterial Vaginosis OTC Drug Sales by Country (2016-2021e) & (K Units)

Table 95. North America Bacterial Vaginosis OTC Drug Sales by Country (2021-2026) & (K Units)

Table 96. North America Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021e) & (USD Million)

Table 97. North America Bacterial Vaginosis OTC Drug Revenue by Country (2021-2026) & (USD Million)

Table 98. North America Bacterial Vaginosis OTC Drug Sales by Type (2016-2021e) & (K Units)

Table 99. North America Bacterial Vaginosis OTC Drug Sales by Type (2021-2026) & (K Units)

Table 100. North America Bacterial Vaginosis OTC Drug Sales by Application (2016-2021e) & (K Units)

Table 101. North America Bacterial Vaginosis OTC Drug Sales by Application (2021-2026) & (K Units)

Table 102. Europe Bacterial Vaginosis OTC Drug Sales by Country (2016-2021e) & (K Units)

Table 103. Europe Bacterial Vaginosis OTC Drug Sales by Country (2021-2026) & (K Units)

Table 104. Europe Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021e) & (USD Million)

Table 105. Europe Bacterial Vaginosis OTC Drug Revenue by Country (2021-2026) & (USD Million)

Table 106. Europe Bacterial Vaginosis OTC Drug Sales by Type (2016-2021e) & (K Units)

Table 107. Europe Bacterial Vaginosis OTC Drug Sales by Type (2021-2026) & (K Units)

Table 108. Europe Bacterial Vaginosis OTC Drug Sales by Application (2016-2021e) & (K Units)

Table 109. Europe Bacterial Vaginosis OTC Drug Sales by Application (2021-2026) & (K Units)

Table 110. Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Region (2016-2021e) & (K Units)

Table 111. Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Region (2021-2026) & (K Units)

Table 112. Asia-Pacific Bacterial Vaginosis OTC Drug Revenue by Region (2016-2021e) & (USD Million)

Table 113. Asia-Pacific Bacterial Vaginosis OTC Drug Revenue by Region (2021-2026) & (USD Million)

Table 114. Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Type (2016-2021e) & (K Units)

Table 115. Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Type (2021-2026) & (K Units)

Table 116. Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Application (2016-2021e) & (K Units)

Table 117. Asia-Pacific Bacterial Vaginosis OTC Drug Sales by Application (2021-2026) & (K Units)

Table 118. South America Bacterial Vaginosis OTC Drug Sales by Country (2016-2021e) & (K Units)

Table 119. South America Bacterial Vaginosis OTC Drug Sales by Country (2021-2026) & (K Units)

Table 120. South America Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021e) & (USD Million)

Table 121. South America Bacterial Vaginosis OTC Drug Revenue by Country (2021-2026) & (USD Million)

Table 122. South America Bacterial Vaginosis OTC Drug Sales by Type (2016-2021e) & (K Units)

Table 123. South America Bacterial Vaginosis OTC Drug Sales by Type (2021-2026) & (K Units)

Table 124. South America Bacterial Vaginosis OTC Drug Sales by Application (2016-2021e) & (K Units)

Table 125. South America Bacterial Vaginosis OTC Drug Sales by Application (2021-2026) & (K Units)

Table 126. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Country (2016-2021e) & (K Units)

Table 127. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Country (2021-2026) & (K Units)

Table 128. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue by Country (2016-2021e) & (USD Million)

Table 129. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue by Country (2021-2026) & (USD Million)

Table 130. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Type (2016-2021e) & (K Units)

Table 131. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Type (2021-2026) & (K Units)

Table 132. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Application (2016-2021e) & (K Units)

Table 133. Middle East & Africa Bacterial Vaginosis OTC Drug Sales by Application (2021-2026) & (K Units)

Table 134. Direct Channel Pros & Cons

Table 135. Indirect Channel Pros & Cons

Table 136. Bacterial Vaginosis OTC Drug Typical Distributors

Table 137. Bacterial Vaginosis OTC Drug Typical Customers

List of Figures

Figure 1. Bacterial Vaginosis OTC Drug Picture

Figure 2. Global Bacterial Vaginosis OTC Drug Sales Market Share by Type in 2020

Figure 3. Pill

Figure 4. Gel

Figure 5. Cream

Figure 6. Other

Figure 7. Global Bacterial Vaginosis OTC Drug Sales Market Share by Application in 2020

Figure 8. Pharmacy

Figure 9. On-line

Figure 10. Other

Figure 11. Global Bacterial Vaginosis OTC Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 12. Global Bacterial Vaginosis OTC Drug Market Size and Forecast (2016-2026) & (USD Million)

Figure 13. Global Bacterial Vaginosis OTC Drug Sales (2016-2026) & (K Units)

Figure 14. Global Bacterial Vaginosis OTC Drug Price by Type (2016-2026) & (US$/Unit)

Figure 15. Global Bacterial Vaginosis OTC Drug Production Capacity (2016-2026) & (K Units)

Figure 16. Global Bacterial Vaginosis OTC Drug Production Capacity by Geographic Region: 2020 VS 2021

Figure 17. Bacterial Vaginosis OTC Drug Market Drivers

Figure 18. Bacterial Vaginosis OTC Drug Market Restraints

Figure 19. Bacterial Vaginosis OTC Drug Market Trends

Figure 20. Global Bacterial Vaginosis OTC Drug Sales Market Share by Manufacturer in 2020

Figure 21. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Manufacturer in 2020

Figure 22. Bacterial Vaginosis OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. Top 3 Bacterial Vaginosis OTC Drug Manufacturer (Revenue) Market Share in 2020

Figure 24. Top 6 Bacterial Vaginosis OTC Drug Manufacturer (Revenue) Market Share in 2020

Figure 25. Global Bacterial Vaginosis OTC Drug Sales Market Share by Region (2016-2026)

Figure 26. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Region (2016-2026)

Figure 27. North America Bacterial Vaginosis OTC Drug Revenue (2016-2026) & (USD Million)

Figure 28. Europe Bacterial Vaginosis OTC Drug Revenue (2016-2026) & (USD Million)

Figure 29. Asia-Pacific Bacterial Vaginosis OTC Drug Revenue (2016-2026) & (USD Million)

Figure 30. South America Bacterial Vaginosis OTC Drug Revenue (2016-2026) & (USD Million)

Figure 31. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue (2016-2026) & (USD Million)

Figure 32. Global Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2026)

Figure 33. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Type (2016-2026)

Figure 34. Global Bacterial Vaginosis OTC Drug Price by Type (2016-2026) & (US$/Unit)

Figure 35. Global Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2026)

Figure 36. Global Bacterial Vaginosis OTC Drug Revenue Market Share by Application (2016-2026)

Figure 37. Global Bacterial Vaginosis OTC Drug Price by Application (2016-2026) & (US$/Unit)

Figure 38. North America Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2026)

Figure 39. North America Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2026)

Figure 40. North America Bacterial Vaginosis OTC Drug Sales Market Share by Country (2016-2026)

Figure 41. North America Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2016-2026)

Figure 42. United States Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2026)

Figure 46. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2026)

Figure 47. Europe Bacterial Vaginosis OTC Drug Sales Market Share by Country (2016-2026)

Figure 48. Europe Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2016-2026)

Figure 49. Germany Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific Bacterial Vaginosis OTC Drug Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific Bacterial Vaginosis OTC Drug Sales Market Share by Region (2016-2026)

Figure 57. Asia-Pacific Bacterial Vaginosis OTC Drug Revenue Market Share by Region (2016-2026)

Figure 58. China Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Japan Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Korea Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. India Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Southeast Asia Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Australia Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South America Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2026)

Figure 65. South America Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2026)

Figure 66. South America Bacterial Vaginosis OTC Drug Sales Market Share by Country (2016-2026)

Figure 67. South America Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Type (2016-2026)

Figure 71. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Application (2016-2026)

Figure 72. Middle East & Africa Bacterial Vaginosis OTC Drug Sales Market Share by Country (2016-2026)

Figure 73. Middle East & Africa Bacterial Vaginosis OTC Drug Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Egypt Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South Africa Bacterial Vaginosis OTC Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source